# FDA Inspection 1066724 - Hangzhou Solipharma Co., Ltd. - August 29, 2018

Source: https://www.keypedia.com/records/fda_inspections/hangzhou-solipharma-co-ltd/638d7f8c-3652-4cbc-8fb4-4ac2015910b1
Source feed: FDA_Inspections

> FDA Inspection 1066724 for Hangzhou Solipharma Co., Ltd. on August 29, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1066724
- Company Name: Hangzhou Solipharma Co., Ltd.
- Inspection Date: 2018-08-29
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1252166 - 2024-09-20](https://www.keypedia.com/records/fda_inspections/hangzhou-solipharma-co-ltd/cb753bd6-2da8-498b-acd9-a14190b08f0b)
- [FDA Inspection 1252166 - 2024-09-20](https://www.keypedia.com/records/fda_inspections/hangzhou-solipharma-co-ltd/06425280-5890-4fb4-b1b8-7ebff10406da)

Company: https://www.keypedia.com/companies/hangzhou-solipharma-co-ltd/5bd44f1f-ef51-49d8-b2ed-05a3b68623a5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c